Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Medical technology company reports sale of obstetrics, cardiovascular businesses
August 11th, 2005
VIASYS Healthcare Inc. (VAS) announced that it has completed the sale of the obstetrics and cardiovascular (OB and CV) businesses that it acquired from Oxford Instruments plc (Oxford) in March, 2005. The OB and CV businesses were sold to Huntleigh Technology plc for approximately UKP4 million (US$6.96 million), subject to an adjustment based on the levels of inventory and fixed assets in the businesses as of the completion date. These businesses, which generated estimated annual revenues of approximately UKP8.5 million (US$14.78 million), are the OB and CV businesses recently acquired by VIASYS when it purchased Oxford's neurophysiology and...
Source: Women's Health Weekly (2005-08-11)
|
